• CME

  • COX-2 Inhibitors for the Prevention of Heterotopic Ossification After THA

  • Author(s)/Faculty: Konstantinos Vlasis, MD; Panayiotis J. Papagelopoulos, MD, DSc; George I. Vasileiadis, MD, PhD; Andreas F. Mavrogenis, MD; George C. Babis, MD, DSc; Ioannis C. Sioutis, MD
    Source: Orthopedics 34:06
    Type: Journal Articles/Items: 1
    Release Date: 6/1/2011 Expiration Date: 6/30/2012
    Credit Type: CME Number of Credit(s): 1
    Cost: $25 Provider: Vindico Medical Education

  • The authors will address the increased possibility of heterotopic ossification after total hip arthroplasty (THA); outline the increased percentage of serious complications with the use of conventional nonsteroidal anti-inflammatory drugs (NSAIDs); identify a safer drug for prophylaxis of heterotopic ossification after THA. 

Educational Objectives

As a result of reading this article, physicians should be able to:

  1. Recognize the increased possibility of heterotopic ossification after total hip arthroplasty (THA).
  2. Outline the increased percentage of serious complications with the use of conventional nonsteroidal anti-inflammatory drugs (NSAIDs).
  3. Identify a safer drug for prophylaxis of heterotopic ossification after THA.
  4. Recognize that the risk of side effects with COX-2 inhibitors is lower compared to conventional NSAIDs and directly related to the time of administration.

This activity is approved for one year from the date of original release, June 1, 2011 to June 30, 2012.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Orthopedics. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is primarily targeted to orthopedic surgeons, hand surgeons, head and neck surgeons, trauma surgeons, physical medicine specialists, and rheumatologists. There is no specific background requirement for participants taking this activity.

How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives and articles, review the presentations, complete the CME test, and complete and submit the registration form and evaluation. Give only one (1) correct answer for each question. A satisfactory score is defined as answering 80% of the questions correctly. Upon receipt of the completed materials, if a satisfactory score on the CME test is achieved, Vindico Medical Education will issue an AMA PRA Category 1™ Certificate within 4 to 6 weeks.

This CME activity is primarily targeted to orthopedic surgeons, hand surgeons, head and neck surgeons, trauma surgeons, physical medicine specialists, and rheumatologists. There is no specific background requirement for participants taking this activity.

Full Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Drs Vasileiadis, Sioutis, Mavrogenis, Vlasis, Babis, and Papagelopoulos have no relevant financial relationships to disclose. Dr D’Ambrosia, Editor-in-Chief, has no relevant financial relationships to disclose. The staff of ORTHOPEDICS have no relevant financial relationships to disclose.

The material presented in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of ORTHOPEDICS or Vindico Medical Education. Neither ORTHOPEDICS nor Vindico Medical Education nor the authors endorse or recommend any techniques, commercial products, or manufacturers. The authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or using any product.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.